GRX: 1,800,000 Series G preferred shares bought at $10.1791

Mario J. Gabelli reported purchasing 1,800,000 Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust at $10.1791 on 10/30/2025.

Accepted by SEC EDGAR 11/05/2025 - 07:19 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Mario J. Gabelli reported purchasing 1,800,000 Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust at $10.1791 on 10/30/2025.

After the trade, reported beneficial ownership totaled 2,000,000 shares indirect via Associated Capital Group, Inc., 400,000 shares indirect via GAMCO Investors, Inc., and 200,000 shares held directly.

Insider Trade Summary

Net Buyer: 1,800,000 shares

Net Buy 1 txn

Insider GABELLI MARIO J

Role Director, 10% Owner

Bought 1,800,000 shs ($18.32M)

Increase in Position 900.0%

Type	Security	Shares	Price	Value
Purchase	Series G Cumulative Preferred Shares	1,800,000	$10.1791	$18.32M
Holding	Series G Cumulative Preferred Shares	--	--	--
Holding	Series G Cumulative Preferred Shares	--	--	--

Holdings After Transaction: Series G Cumulative Preferred Shares — 2,000,000 shares (Indirect, Associated Capital Group, Inc.); Series G Cumulative Preferred Shares — 200,000 shares (Direct); Series G Cumulative Preferred Shares — 400,000 shares (Indirect, GAMCO Investors, Inc.)

Holdings Before and After: Series G Cumulative Preferred Shares, 200,000 to 2,000,000 shares (Indirect, Associated Capital Group, Inc.)

Other Insiders: 1 other insider reported open-market purchases of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The shares reported reflect the total shares owned by Associated Capital Group, Inc. (ACG). Mario J. Gabelli is the Executive Chair and controlling shareholder of ACG. Mr. Gabelli has less than a 100% interest in ACG and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.
2. F2. The shares reported reflect the total shares owned by GAMCO Investors, Inc. (GAMCO). Mario J. Gabelli is the Chairman, Chief Executive Officer, and controlling shareholder of GAMCO. Mr. Gabelli has less than a 100% interest in GAMCO and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did GRX’s insider report on Form 4?

Mario J. Gabelli reported purchasing 1,800,000 Series G Cumulative Preferred Shares at $10.1791 on 10/30/2025.

What is the price per share disclosed in the Form 4 for GRX?

The reported purchase price was $10.1791 per Series G Cumulative Preferred Share.

How many GRX Series G preferred shares were acquired in the reported transaction?

The filing shows an acquisition of 1,800,000 Series G Cumulative Preferred Shares.

What is the reported beneficial ownership after the transaction for GRX?

Reported holdings after the transaction: 2,000,000 shares indirect via Associated Capital Group, Inc., 400,000 shares indirect via GAMCO Investors, Inc., and 200,000 shares held directly.

Which security class is referenced in the GRX Form 4?

The filing concerns Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust.

Who is the reporting person in the GRX Form 4?

The reporting person is Mario J. Gabelli.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GABELLI MARIO J

(Last) (First) (Middle)

C/O GAMCO INVESTORS, INC.

ONE CORPORATE CENTER

(Street)

RYE NY 10580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX.G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)	X	Other (specify below)
			Control Person of Adviser

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series G Cumulative Preferred Shares	10/30/2025		P		1,800,000	A	$10.1791	2,000,000	I	Associated Capital Group, Inc.(1)
Series G Cumulative Preferred Shares								200,000	D
Series G Cumulative Preferred Shares								400,000	I	GAMCO Investors, Inc.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported reflect the total shares owned by Associated Capital Group, Inc. (ACG). Mario J. Gabelli is the Executive Chair and controlling shareholder of ACG. Mr. Gabelli has less than a 100% interest in ACG and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

2. The shares reported reflect the total shares owned by GAMCO Investors, Inc. (GAMCO). Mario J. Gabelli is the Chairman, Chief Executive Officer, and controlling shareholder of GAMCO. Mr. Gabelli has less than a 100% interest in GAMCO and disclaims beneficial ownership of the shares held by it which are in excess of his indirect pecuniary interest.

	Douglas R. Jamieson as Attorney-in-Fact for Mario J. Gabelli	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.